Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study
Indian Journal of Medical Research · 2026
DOI: 10.25259/ijmr_3595_2025 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Indian Journal of Medical Research, 2026. Verfasst von Lakshmi V Divya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Chettinad Academy of Research and Education, Kelambakkam, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Doxorubicin, Cardiotoxicity, Breast Neoplasms, Biomarkers. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background and objectives Doxorubicin is an effective chemotherapeutic agent, whose clinical use is limited by cumulative doxorubicin-induced cardiotoxicity. Early identification of myocardial injury is essential to prevent irreversible cardiac dysfunction. This study evaluated changes in cardiac function and circulating biomarkers associated with early doxorubicin-induced cardiotoxicity.
Methods
Left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) were assessed before and after chemotherapy. Circulating biomarkers, including high-sensitivity C-reactive protein (hs-CRP), high-sensitivity troponin I (hs-Troponin I), Interleukin-33 (IL-33), and miR126-3p, were analysed. Associations between biomarkers and echocardiographic indicators of subclinical cardiac dysfunction were evaluated.
Results
Significant reductions in LVEF (65.00±2.17% to 59.50±5.47%) and GLS (−19.04±1.87% to −15.37±1.79%), increased hs-CRP, and moderate elevations in IL-33 and significant reduction of miR126-3p were observed following doxorubicin therapy. There was a significant association between LVEF with hs-Troponin I ( P =0.03) and IL-33 ( P =0.04), whereas between GLS with hs-Troponin I ( P =0.04), IL-33 ( P =0.04), and miR126-3p ( P= 0.006). Among biomarker inter-association, hs-Troponin I was highly significantly associated with IL-33 ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Chettinad Academy of Research and Education, Kelambakkam, Chennai, Tamil Nadu, India.
- Department of Oncology, Saveetha Institute of Medical and Technical Sciences, Poonamalle, Chennai, Tamil Nadu, India.
- Department of Cardiology, Chitra Hospita, Rajapalayam, Chennai, Tamil Nadu, India.
- Department of Cardiology, Tagore Medical College and Hospital, Rathinamangalam, Chennai, Tamil Nadu, India.
Zitieren
APA
Divya, L. V., Govindaraj, A., Chandra, A. R., Gnanaguru, D., Beautlin, A. J., & Jayapriya, S. (2026). Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study. Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_3595_2025
Vancouver
Divya LV, Govindaraj A, Chandra AR, Gnanaguru D, Beautlin AJ, Jayapriya S. Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study. Indian Journal of Medical Research. 2026. doi:10.25259/ijmr_3595_2025
BibTeX
@article{Divya2026,
author = {Divya, Lakshmi V and Govindaraj, Ashok and Chandra, Anita Ramesh and Gnanaguru, D and Beautlin, Abishkauf Jenish and Jayapriya, S},
title = {Circulating biomarkers for diagnosis of doxorubicin-induced cardiotoxicity in breast cancer patients: A prospective observational study},
journal = {Indian Journal of Medical Research},
year = {2026},
doi = {10.25259/ijmr_3595_2025}
}
EUVIMED